文献速递炎症性肠病消化内镜消化道肿瘤与早癌

在炎症性肠病患者接受色素内镜监测结肠镜检查时,随机活检对肿瘤检出的价值

Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy?
PubMed 文献 · Gut · 2017-01-23

该前瞻性研究纳入1000例接受色素内镜监测结肠镜检查的炎症性肠病患者,在靶向活检或内镜下切除可疑病变后,每10 cm行四象限随机活检。94例患者共发现140处肿瘤性病变,其中112处(80%)来自靶向活检或切除病变,28处(20%)来自随机活检;仅随机活检检出肿瘤的收益为每活检0.2%(68/31865)、每结肠镜检查1.2%(12/1000)、每例肿瘤患者12.8%(12/94)。作者结论认为,尽管随机活检收益低,但对有肿瘤个人史、合并原发性硬化性胆管炎或结肠呈管状外观的患者,应将其与色素内镜联合进行。

要点

  • 1000例炎症性肠病患者接受色素内镜监测结肠镜检查,94例发现肿瘤,140处病变中112处(80%)来自靶向活检或切除病变,28处(20%)来自随机活检。
  • 仅随机活检检出肿瘤的收益为每活检0.2%(68/31865)、每结肠镜检查1.2%(12/1000)、每例肿瘤患者12.8%(12/94)。
  • 随机活检检出异型增生与肿瘤个人史、结肠呈管状外观及合并原发性硬化性胆管炎(PSC)相关。

核心结论

  • 尽管随机活检收益低,作者建议对炎症性肠病合并肿瘤个人史、合并原发性硬化性胆管炎或结肠镜检查时结肠呈管状外观的患者,在色素内镜基础上进行随机活检。

研究设计与样本

  • 前瞻性纳入连续接受色素内镜监测结肠镜检查的炎症性肠病患者,标准化流程为色素内镜、对可疑病变行靶向活检或内镜下切除,然后每10 cm行四象限随机活检。
  • 由五名专家病理学家组成的小组复核异型增生组织切片,采用逻辑回归模型分析与任何活检或随机活检中肿瘤相关的因素。

主要发现

  • 1000例患者(495例溃疡性结肠炎,505例克罗恩结肠炎)共进行1000次结肠镜检查;82例通过靶向活检或切除病变检出肿瘤,其中7例随机活检也检出异型增生;另有12例仅随机活检检出异型增生。
  • 94例患者共发现140处肿瘤性病变,112处(80%)来自靶向活检或切除病变,28处(20%)来自随机活检。
  • 仅随机活检检出肿瘤的收益为每活检0.2%(68/31865)、每结肠镜检查1.2%(12/1000)、每例肿瘤患者12.8%(12/94)。
  • 随机活检检出的异型增生与肿瘤个人史、结肠呈管状外观及合并原发性硬化性胆管炎(PSC)相关。

临床怎么用

  • 作者建议对炎症性肠病合并肿瘤个人史、合并原发性硬化性胆管炎或结肠镜检查时结肠呈管状外观的患者,在色素内镜基础上进行随机活检。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Colonoscopy with pan-chromoendoscopy (CE) is superior to standard colonoscopy in detecting neoplasia in patients with IBD. Performing random biopsies in unsuspicious mucosa after CE remains controversial. METHODS: Consecutive patients with IBD who underwent surveillance colonoscopy using CE were prospectively included. The standardised procedure used CE, performed targeted biopsies or endoscopic resection on suspicious lesions and then quadrant random biopsies every 10 cm. A panel of five expert pathologists reviewed histological slides with dysplasia. Logistic regression model was used to evidence the factors associated with neoplasia in any or in random biopsies. RESULTS: 1000 colonoscopes were performed in 1000 patients (495 UC, 505 Crohn's colitis). In 82 patients, neoplasia was detected from targeted biopsies or removed lesions, and among them dysplasia was detected also by random biopsies in 7 patients. Importantly, in 12 additional patients dysplasia was only detected by random biopsies. Overall, 140 neoplastic sites were found in 94 patients, 112 (80%) from targeted biopsies or removed lesions and 28 (20%) by random biopsies. The yield of neoplasia by random biopsies only was 0.2% per-biopsy (68/31 865), 1.2% per-colonoscopy (12/1000) but 12.8% per-patient with neoplasia (12/94). Dysplasia detected by random biopsies was associated with a personal history of neoplasia, a tubular appearing colon and the presence of primary sclerosing cholangitis (PSC). CONCLUSIONS: Despite their low yield, random biopsies should be performed in association with CE in patients with IBD with a personal history of neoplasia, concomitant PSC or a tubular colon during colonoscopy. TRIAL REGISTRATION NUMBER: IRB 001508, Paris 7 University.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Moussata D, Allez M, Cazals-Hatem D, et al. Are random biopsies still useful for the detection of neoplasia in patients with IBD undergoing surveillance colonoscopy with chromoendoscopy? Gut. 2017. PMID: 28115492. doi:10.1136/gutjnl-2016-311892

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。